Research ExplorerPublicationsPercutaneous vs. surgical axillary access for transcatheter ...

Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry

Standard

Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. / Giordano, Arturo; Schaefer, Andreas; Bhadra, Oliver D; Conradi, Lenard; Westermann, Dirk; DE Backer, Ole; Bajoras, Vilhelmas; Sondergaard, Lars; Qureshi, Waqas T; Kakouros, Nikolaos; Aldrugh, Summer; Amat-Santos, Ignacio; Santos Martínez, Sandra; Kaneko, Tsuyoshi; Harloff, Morgan; Teles, Rui; Nolasco, Tiago; Neves, Jose P; Abecasis, Miguel; Werner, Nikos; Lauterbach, Michael; Sacha, Jerzy; Krawczyk, Krzysztof; Trani, Carlo; Romagnoli, Enrico; Mangieri, Antonio; Condello, Francesco; Regueiro, Ander; Brugaletta, Salvatore; Biancari, Fausto; Niemelä, Matti; Giannini, Francesco; Toselli, Marco; Ruggiero, Rossella; Buono, Andrea; Maffeo, Diego; Bruno, Francesco; Conrotto, Federico; D'Ascenzo, Fabrizio; Savontaus, Mikko; Pykäri, Jouni; Ielasi, Alfonso; Tespili, Maurizio; Corcione, Nicola; Ferraro, Paolo; Morello, Alberto; Albanese, Michele; Biondi-Zoccai, Giuseppe.

In: PANMINERVA MED, Vol. 64, No. 4, 12.2022, p. 427-437.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Giordano, A, Schaefer, A, Bhadra, OD, Conradi, L, Westermann, D, DE Backer, O, Bajoras, V, Sondergaard, L, Qureshi, WT, Kakouros, N, Aldrugh, S, Amat-Santos, I, Santos Martínez, S, Kaneko, T, Harloff, M, Teles, R, Nolasco, T, Neves, JP, Abecasis, M, Werner, N, Lauterbach, M, Sacha, J, Krawczyk, K, Trani, C, Romagnoli, E, Mangieri, A, Condello, F, Regueiro, A, Brugaletta, S, Biancari, F, Niemelä, M, Giannini, F, Toselli, M, Ruggiero, R, Buono, A, Maffeo, D, Bruno, F, Conrotto, F, D'Ascenzo, F, Savontaus, M, Pykäri, J, Ielasi, A, Tespili, M, Corcione, N, Ferraro, P, Morello, A, Albanese, M & Biondi-Zoccai, G 2022, 'Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry', PANMINERVA MED, vol. 64, no. 4, pp. 427-437. https://doi.org/10.23736/S0031-0808.22.04750-4

APA

Giordano, A., Schaefer, A., Bhadra, O. D., Conradi, L., Westermann, D., DE Backer, O., Bajoras, V., Sondergaard, L., Qureshi, W. T., Kakouros, N., Aldrugh, S., Amat-Santos, I., Santos Martínez, S., Kaneko, T., Harloff, M., Teles, R., Nolasco, T., Neves, J. P., Abecasis, M., ... Biondi-Zoccai, G. (2022). Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. PANMINERVA MED, 64(4), 427-437. https://doi.org/10.23736/S0031-0808.22.04750-4

Vancouver

Giordano A, Schaefer A, Bhadra OD, Conradi L, Westermann D, DE Backer O et al. Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. PANMINERVA MED. 2022 Dec;64(4):427-437. https://doi.org/10.23736/S0031-0808.22.04750-4

Bibtex

@article{09fb13854598451fb2ab4ffc8e959594,
title = "Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry",
abstract = "BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established management strategy for severe aortic valve stenosis. Percutaneous axillary approach for TAVI holds the promise of improving safety without jeopardizing effectiveness in comparison to surgical access. We aimed at appraising the comparative effectiveness of percutaneous vs. surgical axillary approaches for TAVI.METHODS: We performed an international retrospective observational study using de-identified details on baseline, procedural, and 1-month follow-up features. Valve Academic Research Consortium (VARC)-3 criteria were applied throughout. Outcomes of interest were clinical events up to 1 month of follow-up, compared with unadjusted and propensity score-adjusted analyses.RESULTS: A total of 432 patients were included, 189 (43.8%) receiving surgical access, and 243 (56.2%) undergoing percutaneous access. Primary hemostasis failure was more common in the percutaneous group (13.2% vs. 4.2%, P<0.001), leading to more common use of covered stent implantation (13.2% vs. 3.7%, P<0.001). Irrespectively, percutaneous access was associated with shorter hospital stay (-2.6 days [95% confidence interval: -5.0; -0.1], P=0.038), a lower risk of major adverse events (a composite of death, myocardial infarction, stroke, type 3 bleeding, and major access-site related complication; odds ratio=0.44 [0.21; 0.95], P=0.036), major access-site non-vascular complications (odds ratio=0.21 [0.06; 0.77], P=0.018), and brachial plexus impairment (odds ratio=0.16 [0.03; 0.76], P=0.021), and shorter hospital stay (-2.6 days [-5.0; -0.1], P=0.038).CONCLUSIONS: Percutaneous axillary access provides similar or better results than surgical access in patients undergoing TAVI with absolute or relative contraindications to femoral access.",
keywords = "Humans, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome, Aortic Valve Stenosis/surgery, Registries, Retrospective Studies, Aortic Valve/surgery, Risk Factors",
author = "Arturo Giordano and Andreas Schaefer and Bhadra, {Oliver D} and Lenard Conradi and Dirk Westermann and {DE Backer}, Ole and Vilhelmas Bajoras and Lars Sondergaard and Qureshi, {Waqas T} and Nikolaos Kakouros and Summer Aldrugh and Ignacio Amat-Santos and {Santos Mart{\'i}nez}, Sandra and Tsuyoshi Kaneko and Morgan Harloff and Rui Teles and Tiago Nolasco and Neves, {Jose P} and Miguel Abecasis and Nikos Werner and Michael Lauterbach and Jerzy Sacha and Krzysztof Krawczyk and Carlo Trani and Enrico Romagnoli and Antonio Mangieri and Francesco Condello and Ander Regueiro and Salvatore Brugaletta and Fausto Biancari and Matti Niemel{\"a} and Francesco Giannini and Marco Toselli and Rossella Ruggiero and Andrea Buono and Diego Maffeo and Francesco Bruno and Federico Conrotto and Fabrizio D'Ascenzo and Mikko Savontaus and Jouni Pyk{\"a}ri and Alfonso Ielasi and Maurizio Tespili and Nicola Corcione and Paolo Ferraro and Alberto Morello and Michele Albanese and Giuseppe Biondi-Zoccai",
year = "2022",
month = dec,
doi = "10.23736/S0031-0808.22.04750-4",
language = "English",
volume = "64",
pages = "427--437",
journal = "PANMINERVA MED",
issn = "0031-0808",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

RIS

TY - JOUR

T1 - Percutaneous vs. surgical axillary access for transcatheter aortic valve implantation: the TAXI registry

AU - Giordano, Arturo

AU - Schaefer, Andreas

AU - Bhadra, Oliver D

AU - Conradi, Lenard

AU - Westermann, Dirk

AU - DE Backer, Ole

AU - Bajoras, Vilhelmas

AU - Sondergaard, Lars

AU - Qureshi, Waqas T

AU - Kakouros, Nikolaos

AU - Aldrugh, Summer

AU - Amat-Santos, Ignacio

AU - Santos Martínez, Sandra

AU - Kaneko, Tsuyoshi

AU - Harloff, Morgan

AU - Teles, Rui

AU - Nolasco, Tiago

AU - Neves, Jose P

AU - Abecasis, Miguel

AU - Werner, Nikos

AU - Lauterbach, Michael

AU - Sacha, Jerzy

AU - Krawczyk, Krzysztof

AU - Trani, Carlo

AU - Romagnoli, Enrico

AU - Mangieri, Antonio

AU - Condello, Francesco

AU - Regueiro, Ander

AU - Brugaletta, Salvatore

AU - Biancari, Fausto

AU - Niemelä, Matti

AU - Giannini, Francesco

AU - Toselli, Marco

AU - Ruggiero, Rossella

AU - Buono, Andrea

AU - Maffeo, Diego

AU - Bruno, Francesco

AU - Conrotto, Federico

AU - D'Ascenzo, Fabrizio

AU - Savontaus, Mikko

AU - Pykäri, Jouni

AU - Ielasi, Alfonso

AU - Tespili, Maurizio

AU - Corcione, Nicola

AU - Ferraro, Paolo

AU - Morello, Alberto

AU - Albanese, Michele

AU - Biondi-Zoccai, Giuseppe

PY - 2022/12

Y1 - 2022/12

N2 - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established management strategy for severe aortic valve stenosis. Percutaneous axillary approach for TAVI holds the promise of improving safety without jeopardizing effectiveness in comparison to surgical access. We aimed at appraising the comparative effectiveness of percutaneous vs. surgical axillary approaches for TAVI.METHODS: We performed an international retrospective observational study using de-identified details on baseline, procedural, and 1-month follow-up features. Valve Academic Research Consortium (VARC)-3 criteria were applied throughout. Outcomes of interest were clinical events up to 1 month of follow-up, compared with unadjusted and propensity score-adjusted analyses.RESULTS: A total of 432 patients were included, 189 (43.8%) receiving surgical access, and 243 (56.2%) undergoing percutaneous access. Primary hemostasis failure was more common in the percutaneous group (13.2% vs. 4.2%, P<0.001), leading to more common use of covered stent implantation (13.2% vs. 3.7%, P<0.001). Irrespectively, percutaneous access was associated with shorter hospital stay (-2.6 days [95% confidence interval: -5.0; -0.1], P=0.038), a lower risk of major adverse events (a composite of death, myocardial infarction, stroke, type 3 bleeding, and major access-site related complication; odds ratio=0.44 [0.21; 0.95], P=0.036), major access-site non-vascular complications (odds ratio=0.21 [0.06; 0.77], P=0.018), and brachial plexus impairment (odds ratio=0.16 [0.03; 0.76], P=0.021), and shorter hospital stay (-2.6 days [-5.0; -0.1], P=0.038).CONCLUSIONS: Percutaneous axillary access provides similar or better results than surgical access in patients undergoing TAVI with absolute or relative contraindications to femoral access.

AB - BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established management strategy for severe aortic valve stenosis. Percutaneous axillary approach for TAVI holds the promise of improving safety without jeopardizing effectiveness in comparison to surgical access. We aimed at appraising the comparative effectiveness of percutaneous vs. surgical axillary approaches for TAVI.METHODS: We performed an international retrospective observational study using de-identified details on baseline, procedural, and 1-month follow-up features. Valve Academic Research Consortium (VARC)-3 criteria were applied throughout. Outcomes of interest were clinical events up to 1 month of follow-up, compared with unadjusted and propensity score-adjusted analyses.RESULTS: A total of 432 patients were included, 189 (43.8%) receiving surgical access, and 243 (56.2%) undergoing percutaneous access. Primary hemostasis failure was more common in the percutaneous group (13.2% vs. 4.2%, P<0.001), leading to more common use of covered stent implantation (13.2% vs. 3.7%, P<0.001). Irrespectively, percutaneous access was associated with shorter hospital stay (-2.6 days [95% confidence interval: -5.0; -0.1], P=0.038), a lower risk of major adverse events (a composite of death, myocardial infarction, stroke, type 3 bleeding, and major access-site related complication; odds ratio=0.44 [0.21; 0.95], P=0.036), major access-site non-vascular complications (odds ratio=0.21 [0.06; 0.77], P=0.018), and brachial plexus impairment (odds ratio=0.16 [0.03; 0.76], P=0.021), and shorter hospital stay (-2.6 days [-5.0; -0.1], P=0.038).CONCLUSIONS: Percutaneous axillary access provides similar or better results than surgical access in patients undergoing TAVI with absolute or relative contraindications to femoral access.

KW - Humans

KW - Transcatheter Aortic Valve Replacement/adverse effects

KW - Treatment Outcome

KW - Aortic Valve Stenosis/surgery

KW - Registries

KW - Retrospective Studies

KW - Aortic Valve/surgery

KW - Risk Factors

U2 - 10.23736/S0031-0808.22.04750-4

DO - 10.23736/S0031-0808.22.04750-4

M3 - SCORING: Journal article

C2 - 35638242

VL - 64

SP - 427

EP - 437

JO - PANMINERVA MED

JF - PANMINERVA MED

SN - 0031-0808

IS - 4

ER -